These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35456564)

  • 1. Preparation of Aditoprim Injection against
    Qu W; Dong M; Pan Y; Xie S; Yuan Z; Huang L
    Pharmaceutics; 2022 Mar; 14(4):. PubMed ID: 35456564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic-pharmacodynamic modeling of tylosin against Streptococcus suis in pigs.
    Huang L; Zhang H; Li M; Ahmad I; Wang Y; Yuan Z
    BMC Vet Res; 2018 Oct; 14(1):319. PubMed ID: 30355326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A physiologically based pharmacokinetic/pharmacodynamic model to determine dosage regimens and withdrawal intervals of aditoprim against
    Mi K; Sun L; Zhang L; Tang A; Tian X; Hou Y; Sun L; Huang L
    Front Pharmacol; 2024; 15():1378034. PubMed ID: 38694922
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibacterial activity of combined aditoprim and sulfamethoxazole against Escherichia coli from swine and a dose regimen based on pharmacokinetic-pharmacodynamic modeling.
    Wang F; Luo W; Pan Y; Qu W; Xie S; Huang L; Wang Y
    J Vet Pharmacol Ther; 2022 Jan; 45(1):133-145. PubMed ID: 34435681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation of a rational dosage regimen of ceftiofur hydrochloride oily suspension by pharmacokinetic-pharmacodynamic (PK-PD) model for treatment of swine
    Luo W; Wang D; Qin H; Chen D; Pan Y; Qu W; Huang L; Xie S
    J Vet Sci; 2021 Nov; 22(6):e41. PubMed ID: 34854264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PK-PD Modeling and Optimal Dosing Regimen of Acetylkitasamycin against
    Huang A; Mao F; Huang L; Xie S; Pan Y; Qu W; Cheng G; Liu Z; Yuan Z; Peng D; Hao H
    Antibiotics (Basel); 2022 Feb; 11(2):. PubMed ID: 35203885
    [No Abstract]   [Full Text] [Related]  

  • 7. PK-PD Integration Modeling and Cutoff Value of Florfenicol against
    Lei Z; Liu Q; Yang S; Yang B; Khaliq H; Li K; Ahmed S; Sajid A; Zhang B; Chen P; Qiu Y; Cao J; He Q
    Front Pharmacol; 2018; 9():2. PubMed ID: 29387013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synovial and Systemic Pharmacokinetics of Florfenicol and PK/PD Integration against
    Somogyi Z; Mag P; Kovács D; Kerek Á; Szabó P; Makrai L; Jerzsele Á
    Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35057005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of Susceptibility Breakpoint for Cefquinome against
    Mi K; Li M; Sun L; Hou Y; Zhou K; Hao H; Pan Y; Liu Z; Xie C; Huang L
    Antibiotics (Basel); 2021 Aug; 10(8):. PubMed ID: 34439008
    [No Abstract]   [Full Text] [Related]  

  • 10. Integration of PK/PD for dose optimization of aditoprim against Trueperella pyogenes causing endometritis in bovines.
    Maan MK; Sattar A; Mi K; Bakr Shabbir MA; Xie S; Xin L; Ahmed S; Algharib SA; Huang L; Yuan Z
    Microb Pathog; 2020 Feb; 142():104097. PubMed ID: 32105803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PK-PD Analysis of Marbofloxacin against
    Lei Z; Liu Q; Yang B; Khaliq H; Cao J; He Q
    Front Pharmacol; 2017; 8():856. PubMed ID: 29209222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosing Regimen of Aditoprim and Sulfamethoxazole Combination for the
    Huang A; Huang X; Zhang Z; Yuan Z; Huang L; Wang Y; Tao Y; Chen D; Liu Z; Hao H
    Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297496
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacodynamic Evaluation and PK/PD-Based Dose Prediction of Tulathromycin: A Potential New Indication for
    Zhou YF; Peng HM; Bu MX; Liu YH; Sun J; Liao XP
    Front Pharmacol; 2017; 8():684. PubMed ID: 29033841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose Optimization of Aditoprim-Sulfamethoxazole Combinations Against
    Maan MK; Chaudhry TH; Sattar A; Shabbir MAB; Ahmed S; Mi K; Ahmed W; Xie S; Xin L; Huang L
    Front Pharmacol; 2021; 12():753359. PubMed ID: 34867364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic Target Assessment and PK/PD Cutoff Determination for Gamithromycin Against
    Wang RL; Liu P; Chen XF; Yao X; Liao XP; Liu YH; Sun J; Zhou YF
    Front Vet Sci; 2022; 9():945632. PubMed ID: 35898553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic-Pharmacodynamic Modeling of Enrofloxacin Against Escherichia coli in Broilers.
    Sang K; Hao H; Huang L; Wang X; Yuan Z
    Front Vet Sci; 2015; 2():80. PubMed ID: 26779495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial activity of cyadox against Clostridium perfringens in broilers and a dosage regimen design based on pharmacokinetic-pharmacodynamic modeling.
    Wang F; Mi K; Ahmad I; Xie S; Hussain HI; Yuan Z; Dai M; Huang L
    Microb Pathog; 2020 Apr; 141():103981. PubMed ID: 31962185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dose regimen formulation of tilmicosin against Lawsonia intracellularis in pigs by pharmacokinetic-pharmacodynamic (PK-PD) model.
    Luo W; Qin H; Chen D; Wu M; Meng K; Zhang A; Pan Y; Qu W; Xie S
    Microb Pathog; 2020 Oct; 147():104389. PubMed ID: 32707311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PK/PD modeling of Ceftiofur Sodium against Haemophilus parasuis infection in pigs.
    Li XD; Chi SQ; Wu LY; Liu C; Sun T; Hong J; Chen X; Chen XG; Wang GS; Yu DJ
    BMC Vet Res; 2019 Aug; 15(1):272. PubMed ID: 31370843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo antibacterial effect of NZ2114 against Streptococcus suis type 2 infection in mice peritonitis models.
    Jiao J; Mao R; Teng D; Wang X; Hao Y; Yang N; Wang X; Feng X; Wang J
    AMB Express; 2017 Dec; 7(1):44. PubMed ID: 28220445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.